Board of Directors

ICCBBA is governed by a volunteer Board of Directors comprising leading experts in blood transfusion, cellular therapy, and tissue transplantation from around the world.  Board positions are advertised publicly and Board members normally serve six year terms.  The current Board of Directors has members from China, Denmark, Egypt, the Netherlands, Singapore, the United Kingdom, and the United States.

ICCBBA Board of Directors

 

 

Chairman:        Merlyn H. Sayers

Vice-Chairman: Jørgen Georgsen

Treasurer:        Richard E. Brown  

Secretary:        Suzanne Butch
 

Scott Brubaker

Faten Moftah
Ineke Slaper-Cortenbach
Diana Teo
Ruth Warwick
 

Yong Ming Zhu

 

Biographies

 

Chairman:

Merlyn H. Sayers, MBBCH, PhD 

USA

Merlyn SayersCarter BloodCare’s Chief Executive Officer, Dr. Merlyn H. Sayers, is a physician with 25 years experience in blood banking and transfusion medicine. 

He was born in Reading, Berkshire, England, and received his medical degree and Ph.D. from the University of Witwatersrand in Johannesburg in 1978. 

He has held position of President and Chief Executive Officer at Carter BloodCare in Dallas/Fort Worth/Waco since its formation in 1998. 

Before coming to Texas, Dr. Sayers spent 15 years in Seattle with the Puget Sound Blood Center where he was also on the faculty at the University of Washington in the Department of Medicine. 

 He has previously held positions of Chairman of the Food and Drug Administration’s Blood Products Advisory Committee, Vice Chairman of the Washington State Board of Health, committee member on the Health and Human Services Advisory Committee on Blood Safety and Availability, and Vice Chairman of the AABB's Scientific Section Coordinating Committee. 

Dr. Sayers is also a Professor in the Department of Pathology at the University of Texas Southwestern Medical Center and he is Past President of America’s Blood Centers.

 

Vice-Chairman:

Jørgen Georgsen, MD

  DENMARK

Jorgen GeorgsenJørgen Georgsen is from Odense University (1981). Specialist in clinical immunology (1990) after training in Aalborg Hospital and State University Hospital (Copenhagen, Rigshospitalet). Assistant Medical Director (1991), later Medical Director (2001), Department of Clinical Immunology, Odense University Hospital. Former secretary, treasurer and chairman of the Danish Society for Clinical Immunology. Current Chairman of this Society’s Working Group on Transfusion Medicine.  Editor of the Danish Transfusion Medicine Standards.  Chairman of the Organisation of Transfusion Centres in Denmark. Executive member of the Board of the European Blood Alliance. Former member of the ISBT WPADP. Former chairman, current member of MEETAG. Member of ICCBBA’s Editorial Board. Member of the Board of ICCBBA.

 

  

Treasurer:  

Richard E. Brown, MS, BS, BA, MT(ASCP)  

 USA

Richard BrownRichard E. Brown has spent over 35 years in the clinical laboratory, blood banking, and executive administration positions.  He is a retired US Army Colonel who started his career operating and managing military hospital laboratories in small hospitals to Army Medical Centers including the largest US military medical center in Europe.  He specialized in blood banking and had an extensive career technically and administratively directing blood collection first in hospitals and medical centers and then for the entire US Army Medical Department.  He became the Army Blood Program Manager responsible for the collection and transfusion of blood and blood products Army wide.  He was the Alternate Responsible Head for the US Army FDA license, setting up the compliance structure in place 10 years later. He served as blood banking consultant to the US Army Surgeon General for nearly 6 years.  In his final military assignment he directed the individual training of all Army Medical Laboratory Technicians (MLT), Pharmacy Technicians and Radiology Technicians.  He was recruited by the American Red Cross to restructure their manufacturing operation in Atlanta, GA and then went on to their Los Angeles region.  He helped design, build, commission and place into operation the largest blood processing laboratory at that time in the American Red Cross system.  He served as Vice President for Global Laboratory Operations at StemCyte Inc., an umbilical cord blood stem cell bank.  

 

 

Secretary:

Suzanne Butch, MA, MT(ASCP) SBB

 USA

Suzanne ButchSuzanne Butch is the Administrative Manager of the Blood Bank and Transfusion Service of the University of Michigan Hospitals in Ann Arbor, Michigan. She holds a bachelor’s degree from the University of Michigan and a master’s degree from Central Michigan University.  She is certified as a Clinical Laboratory Scientist and Laboratory Director from the NCA, as a Medical Technologist and a Specialist in Blood Banking from the ASCP and as a Certified Quality Auditor from the American Society for Quality.

She has been active in state, national and international professional societies and edited books on irradiation and information technology in transfusion medicine.  She currently serves as a member of the  AABB Coding and Reimbursement Committee, the AABB Annual Meeting Program Unit, and as chair of the Management Examination Committee of the National Credentialing Agency for Laboratory Personnel. She has served as a member and advisor to the CLSI Committee on Automation and on the US Technical Advisory Group for ISO/TC 212 and ISO/TC 76.

Among her professional concerns are the use of bar coding and streamlining laboratory operations. To this end she has worked since 1990 on various committees and organizations to promote the electronic crossmatch and furthering the use of automation in the transfusion service. She has been a member and chair of  ICCBBA’s America's Technical Advisory Group (ATAG).

 

Scott Brubaker, CTBS

USA

Scott Brubaker

Since August of 2004, Scott has held the position of Chief Policy Officer at the American Association of Tissue Banks (AATB) located in McLean, Virginia. His main duties are to liaison with the FDA, the CDC, and other professional organizations nationally and internationally who are standards-setting or regulating bodies for cell and tissue donation, banking, and transplantation.  He also serves as the office liaison for the AATB’s Standards Committee and Physicians’ Council, and leads the Association’s membership in the creation of new standards and guidance documents.  Prior to joining the AATB, he acquired 18 years of practical experience in tissue banking and organ donation at Virginia Tissue Bank/LifeNet.  Scott regularly provides educational presentations that cover tissue banking and transplant safety.

 

Faten Moftah, MD

 EGYPT

Fatan MoftahFaten Moftah is currently the Director General for the National Blood Transfusion Services, Ministry of Health (MOH) in Egypt since 1999.  Not only is she the Director General, she also sits as the Chairperson on the Board of Directors.  She is the chair of the Egyptian Fellowship Board for Transfusion Medicine, the Chair of the National Advisory Committee for Blood Transfusion, and the Chair of the Scientific Committee of Blood Consumables in the National Pharmaceutical Regulator.  She is a member of ICCBBA’s Middle East and European Technical Advisory Group (MEETAG) and the International Society for Blood Transfusion (ISBT), where she served as the Regional Director from 2002 to 2006.  She currently is a consultant for The World Health Organization (WHO), an executive member of the Arabic Speaking countries Transfusion Medicine Courses (ATMC) and a member of the Arab Association of Transfusion Medicine.

 

 

Ineke Slaper-Cortenbach, PhD

NETHERLANDS

Ineke Slaper-CortenbachIneke C.M. Slaper-Cortenbach is the Director of both the Gene and Cell Therapy Facility and the Stem Cell Transplantation Laboratory at the University Medical Center Utrecht (UMC Utrecht) in the Netherlands. She has nearly 25 years of experience as laboratory director of a stem cell transplantation lab and her current focus is on Mesenchymal Stromal Cells and translational research.

 

At the UMC Utrecht, she works closely with investigators and clinicians from different divisions in the Regenerative Medicine Program. 

 

She has been involved in several professional organizations and has served as the president and vice-president of JACIE (Joint Accreditation Committee of ISCT and EBMT).

 

Her present activities include

  • Co-chair of the FACT/JACIE processing standards committee
  • Representative for ISCT in AHCTA (Alliance for Harmonisation of Cellular Therapy Accreditation)
  • Regional vice president-elect for ISCT in Europe
  • Member of the Board of ISCT-Europe
  • Chair of the ISCT European Legal and Regulatory Affairs Committee
  • Editor of the journal Cytotherapy
  • Chair of the scientific committee of the second ISCT-Europe regional meeting (Belgirate 2010)
  • Co-chair of the scientific committee of the annual ISCT-meeting in 2011

Since 2009, she has been a member of the Expert Group on Advanced Therapy Medicinal Products of the Medicines Evaluation Board (CBG) in the Netherlands. She is also the current chair of the International Cellular Therapy Coding and Labeling Advisory Group.

 

Diana Teo, MD

SINGAPORE

Diana TeoDiana Teo graduated from National University of Singapore in 1982 with an M.B.,B.S. degree. Obtained Master of Science degree in Medical Immunology from the University of London, followed by Membership of the Royal College of Pathologists, UK in 1993, and Fellowship of the Royal College of Pathologists in 2001. Accredited by the UK General Medical Council Specialist  Register in the Speciality of Immunology, and Certificate of Specialist Accreditation, Ministry of Health, Singapore in the Speciality of Pathology. Awarded the Singapore National Day Honours Public Administration Medal  (Silver) in 2008.

 Appointed Director, Centre for Transfusion Medicine, Health Sciences Authority (HSA) since January 2003, and the Group Director, Blood Services Group, HSA since August 2008.  Chairman of the HSA Professional Board since January 2009. The Blood Services Group is the national blood service in Singapore, and is AABB accredited in blood banking and transfusion medicine and ASHI accredited in tissue typing. The Blood Services Group is also a WHO Collaborating Centre for Transfusion Medicine. Other relevant appointments include the Ministry of Health Specialist Training Committee for Haematology, President of the Singapore Society of Haematology from 2002 to 2004,  Member of the Board of Directors (Asia-Pacific Region Director) for International Society of Blood Transfusion, Vice Chair of the Asia Pacific Blood Network, Member of the WHO Expert Advisory Panel for Transfusion Medicine, and Member of the Board of Directors for ICCBBA.  

Main interests within Transfusion Medicine include organizational and quality systems in blood transfusion services, blood safety, and global development in transfusion medicine.

 

 

 

Ruth M Warwick MB, ChB

 UK

Ruth WarwickRuth Warwick is qualified in Medicine from Bristol University UK (1973) and specialized in clinical hematology (Royal Free, Hillingdon & Hammersmith Hospitals). Worked in Transfusion Medicine and as Consultant Specialist for Tissue Services for the National Health Service Blood & Transplant (NHSBT) from 1993.  Fellow of the Royal College of Physicians MRCP 1977, FRCP 1997 & Fellow of the Royal College of Pathologists MRCPath 1980,  FRCPath 1992.  Immediate past President of the European Association of Tissue Banks (2007-2009), past President of British Association for Tissue Banking (2006-2008), Chairman EC CEN ISSS Workshop on Coding & Traceability of Tissues & Cells (2007-2008). Has had national & international experience in policy setting  such as the founder Chair of the  National Institute for Biological Standards & Controls /UK Blood Services Tissues Advisory Committee for Tissues and Haemopoietic Stem Cells (1995-2001), Consultant for the Council of Europe Expert Group on Organs Tissues & Cells (1999- 2001) & advisory roles for the English Department of Health Transplant Policy Unit & Human Tissue Authority.  She has over 100 published papers, edited volumes including lead editor of a multinational book in Tissue Donation (published 2009), chapters, and letters. 

 

 

  

 

ZHU Yong Ming, Professor

CHINA

Zhu MingZhu Yong Ming's current position is President of Shanghai (Red Cross)Blood Center and the Director of WHO CollaboratingCenter for Blood Transfusion Services.

Career in transfusion medicine started in August 1984 by serving as a technician in immunogenetic laboratory of SBC, till 1990 over ten papers published, either alone or as co-author, with histocompatibility and application of computer science as main focuses. 

In early 1990 joined Shanghai RAAS Blood Products Co. Ltd. as the Production Manager, and became the Deputy Technical Director three years later. Shanghai RAAS is one of the major plasma fractionators in China, and was the first one in China to market virus inactivated clotting factors and liquid IVIG.

In mid-1996 left Shanghai RAAS while holding the post as Deputy General Manager for Technical Affairs, and coming back to SBC as the Director of Administration Office, the decision of adopting ISBT 128 in SBC was made in this post. Before being promoted as the President of SBC in 2001, served as a VP for two years.  

Some of the present positions in professional organizations are: Vice President of ISBT (2002-2006, International Society of Blood Transfusion), Vice-Chairman of CSBT (Chinese Society of Blood Transfusion), Chairman of Blood Quality Management Committee of CSBT, Board Director of ICCBBA (International Council for Commonality in Blood Banking Automation), Councilor of ICBS (International Consortium of Blood Safety), etc. Holding memberships in various societies in medicine, genetics, biochemistry, Molecular Biology, and in editorial boards of major Journals in Hematology and Transfusion Medicine in China. Teaching transfusion medicine as guest professor to undergraduates and postgraduates of Shanghai Jiaotong University Medical School and East China Normal University, etc.

Recent professional activities include giving theme speeches at National Conference of CSBT, addressing or chairing symposia and/or conference sessions of ISBT, IABs (International Association for Biologicals), PPTA and IFRERCS. Published over 20 articles, numerous congress abstracts or seminar textbooks on transfusion medicine and related areas, the management of blood program and blood services.